Shalina Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2021 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24299MH2021PTC364251. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹25.00 K .
Employing 1 professional, Its leadership includes Sundar Sankaran (Nominee Director), Prasad Shyamsunder Deshpande (Director), Shalina Clifford (Director). Past directors included Desh Deepak Misra, Prasad Shyamsunder Deshpande, Shalina Clifford. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 96,97, Floor-9, Plot-220, Maker Chambers Jamnalal Bajaj Marg, Nariman Point,, Mumbai, Maharashtra, 400021.
U24299MH2021PTC364251
364251
20 July 2021
₹1.50 M
₹25.00 K
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shalina Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sundar Sankaran | Nominee Director | 20 Jul 2021 | Current |
| Prasad Shyamsunder Deshpande | Director | 02 Feb 2024 | Current |
| Shalina Clifford | Director | 24 Sep 2021 | Current |
| Fazle Abbas Virji | Director | 24 Sep 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 01 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 01 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 01 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Shalina Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Shalina Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shalina Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shalina Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shalina Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shalina Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Shalina Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Prasad Shyamsunder Deshpande was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
Shalina Clifford was appointed as a Director was appointed as a Director on 24 Sep 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Fazle Abbas Virji was appointed as a Director was appointed as a Director on 24 Sep 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Sundar Sankaran was appointed as a Nominee Director was appointed as a Nominee Director on 20 Jul 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
The CIN of Shalina Pharmaceuticals Private Limited is U24299MH2021PTC364251.
Shalina Pharmaceuticals Private Limited is headquartered at 96,97, Floor-9, Plot-220, Maker Chambers Jamnalal Bajaj Marg, Nariman Point,, Mumbai, Maharashtra, 400021.
Shalina Pharmaceuticals Private Limited was incorporated on 20 July 2021.
The current directors of Shalina Pharmaceuticals Private Limited are
The primary industry of Shalina Pharmaceuticals Private Limited is Pharma.
Shalina Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shalina Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹25.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX